10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Roivant Sciences Ltd. (ROIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | QVT Financial Daniel Gold | 65,793,779 | $778,340,406 | 69.36% | |
| 2. | Viking Global Andreas Halvorsen | 47,809,960 | $565,591,827 | -12% | 1.83% |
| 3. | Rubric Capital Management David Rosen | 20,000,000 | $236,600,000 | -11% | 3.03% |
| 4. | Two Seas Capital Sina Toussi | 10,167,807 | $120,285,157 | +5% | 10.39% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 6,131,948 | $72,540,945 | -30% | 0.49% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 4,000,000 | Large Shareholder | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | Large Shareholder | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | Large Shareholder | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.43 | 227,500 | 163,264 | 2025-02-13 | Filing | ||
| $10.42 | 218,041 | 896,869 | 2025-02-13 | Filing | ||
| $10.53 | 217,384 | 732,294 | 2025-02-12 | Filing | ||
| $11.28 | 100,000 | 732,294 | 2025-01-21 | Filing | ||
| $11.54 | 177,704 | 740,976 | 2024-12-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 62,057,537 | $734,140,663 | 6.44% | |
| 2. | 49,301,583 | $583,237,729 | 0.03% | |
| 3. | 44,087,287 | $521,552,605 | 0% | |
| 4. | 42,157,531 | $498,723,591 | 0.01% | |
| 5. | 34,615,073 | $409,496,322 | 0.02% |
News See All
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to a Roivant Sciences Ltd. second quarter 2024 earnings call. At this time, all participants are in a listen-only mode.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
Several Positive Developments Lifted Roivant (ROIV) in Q3
Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Roivant Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
8 High Growth UK Stocks to Invest In
According to a KPMG report, the United Kingdom’s GDP growth is projected to slow in the second half of 2024 but is expected to rise slightly to 1.2% in 2025.
10 Most Promising Mid-Cap Stocks According to Hedge Funds
September closed on a high note, opening a wealth of opportunities for investors.
10 Best NASDAQ Stocks Under $20 to Buy
The close of September has seen the much awaited interest rate cut from the Federal Reserve materialize.
Billionaire Hedge Funds
